Literature DB >> 14978122

The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells.

Matthias Hesse1, Ciriaco A Piccirillo, Yasmine Belkaid, Jeannette Prufer, Margaret Mentink-Kane, Mary Leusink, Allen W Cheever, Ethan M Shevach, Thomas A Wynn.   

Abstract

IL-10 reduces immunopathology in many persistent infections, yet the contribution of IL-10 from distinct cellular sources remains poorly defined. We generated IL-10/recombination-activating gene (RAG)2-deficient mice and dissected the role of T cell- and non-T cell-derived IL-10 in schistosomiasis by performing adoptive transfers. In this study, we show that IL-10 is generated by both the innate and adaptive immune response following infection, with both sources regulating the development of type-2 immunity, immune-mediated pathology, and survival of the infected host. Importantly, most of the CD4(+) T cell-produced IL-10 was confined to a subset of T cells expressing CD25. These cells were isolated from egg-induced granulomas and exhibited potent suppressive activity in vitro. Nevertheless, when naive, naturally occurring CD4(+)CD25(+) cells were depleted in adoptive transfers, recipient IL-10/RAG2-deficient animals were more susceptible than RAG2-deficient mice, confirming an additional host-protective role for non-T cell-derived IL-10. Thus, innate effectors and regulatory T cells producing IL-10 cooperate to reduce morbidity and prolong survival in schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978122     DOI: 10.4049/jimmunol.172.5.3157

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  149 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 2.  Macrophage activation governs schistosomiasis-induced inflammation and fibrosis.

Authors:  Luke Barron; Thomas A Wynn
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

Review 3.  CD4+ regulatory cells as a potential immunotherapy.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 4.  Regulatory T cells in microbial infection.

Authors:  Jocelyne Demengeot; Santiago Zelenay; Maria Francisca Moraes-Fontes; Iris Caramalho; António Coutinho
Journal:  Springer Semin Immunopathol       Date:  2006-07-28

5.  Increase of CD4(+)CD25(+) T cells in Smad3(-/-) mice.

Authors:  Zi-Bing Wang; Yu-Fang Cui; Yu-Qing Liu; Wei Jin; Han Xu; Zhu-Jun Jiang; Ya-Xin Lu; Ying Zhang; Xiao-Lan Liu; Bo Dong
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 6.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection.

Authors:  James M Ertelt; Jared H Rowe; Tanner M Johanns; Joseph C Lai; James B McLachlan; Sing Sing Way
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  Induction and regulation of pathogenic Th17 cell responses in schistosomiasis.

Authors:  Bridget M Larkin; Patrick M Smith; Holly E Ponichtera; Mara G Shainheit; Laura I Rutitzky; Miguel J Stadecker
Journal:  Semin Immunopathol       Date:  2012-10-25       Impact factor: 9.623

Review 9.  Role of endogenous and induced regulatory T cells during infections.

Authors:  Elizabeth Wohlfert; Yasmine Belkaid
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

10.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.